Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
- Resource Type
- Correspondence
- Source
- In
European Journal of Cancer March 2024 200 - Subject
- Language
- ISSN
- 0959-8049